News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,077 Results
Type
Article (41928)
Company Profile (435)
Press Release (664714)
Section
Business (208566)
Career Advice (2016)
Deals (35985)
Drug Delivery (98)
Drug Development (83449)
Employer Resources (170)
FDA (16371)
Job Trends (15064)
News (352422)
Policy (33013)
Tag
Academia (2620)
Alliances (50833)
Alzheimer's disease (1347)
Approvals (16328)
Artificial intelligence (203)
Bankruptcy (365)
Best Places to Work (11834)
Biotechnology (329)
Breast cancer (221)
Cancer (1665)
Cardiovascular disease (132)
Career advice (1681)
CAR-T (118)
Cell therapy (347)
Clinical research (66885)
Collaboration (657)
Compensation (344)
COVID-19 (2617)
C-suite (152)
Data (1550)
Diabetes (208)
Diagnostics (6302)
Earnings (86433)
Employer resources (147)
Events (114149)
Executive appointments (550)
FDA (17222)
Funding (592)
Gene therapy (247)
GLP-1 (677)
Government (4439)
Healthcare (19082)
Infectious disease (2721)
Inflammatory bowel disease (121)
Interviews (309)
IPO (16712)
Job creations (3698)
Job search strategy (1431)
Layoffs (461)
Legal (7955)
Lung cancer (248)
Manufacturing (235)
Medical device (13396)
Medtech (13401)
Mergers & acquisitions (19592)
Metabolic disorders (559)
Neuroscience (1764)
NextGen: Class of 2025 (6750)
Non-profit (4544)
Northern California (1984)
Obesity (318)
Opinion (209)
Patents (142)
People (58124)
Phase I (21015)
Phase II (29526)
Phase III (21809)
Pipeline (669)
Postmarket research (2600)
Preclinical (8961)
Radiopharmaceuticals (256)
Rare diseases (326)
Real estate (6002)
Regulatory (22301)
Research institute (2406)
Resumes & cover letters (351)
Southern California (1733)
Startups (3754)
United States (18104)
Vaccines (619)
Weight loss (221)
Date
Today (136)
Last 7 days (620)
Last 30 days (2834)
Last 365 days (35731)
2025 (3295)
2024 (36300)
2023 (41016)
2022 (52276)
2021 (56764)
2020 (54923)
2019 (47420)
2018 (35697)
2017 (33028)
2016 (32348)
2015 (38397)
2014 (32189)
2013 (27110)
2012 (29222)
2011 (29866)
2010 (27996)
Location
Africa (733)
Arizona (215)
Asia (38864)
Australia (6467)
California (4612)
Canada (1644)
China (380)
Colorado (209)
Connecticut (225)
Europe (84791)
Florida (658)
Georgia (158)
Illinois (460)
Indiana (254)
Maryland (729)
Massachusetts (3617)
Michigan (195)
Minnesota (332)
New Jersey (1302)
New York (1309)
North Carolina (872)
Northern California (1984)
Ohio (166)
Pennsylvania (1066)
South America (1107)
Southern California (1733)
Texas (675)
Utah (138)
Washington State (468)
707,077 Results for "sirna therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
December 18, 2024
·
3 min read
Press Releases
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
January 7, 2025
·
5 min read
Genetown
Aphios Granted US Patent For siRNA Targeted Therapeutics for Treatment of HIV-1 and Other Diseases
Aphios Corporation announced today that it has been granted US Patent No. 11,981,174 for CCR5 and CD4 siRNA-targeted therapeutics for treatment of HIV-1 and other diseases.
May 15, 2024
·
2 min read
Press Releases
Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs
November 26, 2024
·
10 min read
Press Releases
Sirius Therapeutics Announces Promising Phase I Clinical Data from Its Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders
December 9, 2024
·
3 min read
Press Releases
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity
December 23, 2024
·
5 min read
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
Altamira Therapeutics Ltd. today announced that it has filed a provisional patent application with the United States Patent Office (USPTO) which covers nanoparticles comprising the Company’s OligoPhore™ platform and siRNA targeting the p65 protein, a component of the NF-κB transcription factor.
May 1, 2024
·
8 min read
Press Releases
Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions
November 18, 2024
·
3 min read
Press Releases
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
October 31, 2024
·
9 min read
Press Releases
Comanche Biopharma Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway (ILAP) Steering Group for CBP-4888, an Investigational siRNA Drug Candidate for the Treatment of sFlt1-mediated Preterm Preeclampsia
January 30, 2025
·
4 min read
1 of 70,708
Next
